S, B., FL, D., P, B., U, C., P, F., E, D., . . . S, T. (2010). Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure. The American journal of cardiology, 105(6), 853. https://doi.org/10.1016/j.amjcard.2009.11.038
Chicago Style (17th ed.) CitationS, Buralli, Dini FL, Ballo P, Conti U, Fontanive P, Duranti E, Metelli MR, Marzilli M, and Taddei S. "Circulating Matrix Metalloproteinase-3 and Metalloproteinase-9 and Tissue Doppler Measures of Diastolic Dysfunction to Risk Stratify Patients with Systolic Heart Failure." The American Journal of Cardiology 105, no. 6 (2010): 853. https://doi.org/10.1016/j.amjcard.2009.11.038.
MLA (9th ed.) CitationS, Buralli, et al. "Circulating Matrix Metalloproteinase-3 and Metalloproteinase-9 and Tissue Doppler Measures of Diastolic Dysfunction to Risk Stratify Patients with Systolic Heart Failure." The American Journal of Cardiology, vol. 105, no. 6, 2010, p. 853, https://doi.org/10.1016/j.amjcard.2009.11.038.